News
News from us and our partners
Tags
Topics
0 results
- News
AFYREN and MINASOLVE Announce Partnership Agreement to Jointly Develop Key Bio-Based Molecules for the Fragrances Industry at Industrial Scale
- News
Alethio Therapeutics Raises $90 Million (£67 Million) in Oversubscribed Series A Financing to Advance a New Generation of Therapies for Myeloproliferative Neoplasms
- News
Hemab Therapeutics to Present Clinical and Preclinical Data from Multiple Blood Coagulation Programs at the 68th ASH Annual Meeting and Exposition
- News
Biotalys’ First Commercial Biofungicide EVOCA® NG Approved for Large-Scale Commercial Field Trials in the Netherlands
- News
BrightHeart Expands Its AI Platform in Europe to Bring Greater Confidence and Consistency to Prenatal Ultrasound
- News
Sofinnova Partners promotes Javier Nunez-Vicandi to Partner, strengthening its Digital Medicine strategy
- News
Qorium Becomes Reyva as Cultivated Leather Company Moves Towards Commercial Scale
- News
Purespring Therapeutics advances kidney-targeted gene therapy PS-003 towards the clinic in X-linked Alport Syndrome
- News
DMC secures $18M to expand health ingredients business
- News
CorWave completes enrollment in feasibility study and presents first clinical data on adaptive support with its Wave Membrane LVAD
- News
Muna Therapeutics announces positive Phase 1 results supporting potential of oral small-molecule TREM2 Modulator in Alzheimer’s disease
- News
TISSIUM® receives CE Mark for ECLIPSIUM®, Its atraumatic hernia repair solution
- News
F2G and Shionogi report data from Global Phase 3 OASIS Study evaluating investigational oral Olorofim versus AmBisome
- News
Bionyra Pharma Announces Positive Interim Phase 1 Results for BYN-002, a Long-Acting Anti-TL1A Antibody
- News
IMIO Raises $12M from Sofinnova Partners and Chipotle's Cultivate Next to Scale Reliable Biologicals and Improve Soil Performance